脑白质高信号患者血清CX3CL1水平与认知功能障碍的关系

doi:10.3969/j.issn.1006-7795.2023.01.002

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (1): 6-12.doi: 10.3969/j.issn.1006-7795.2023.01.002

• 临床流行病和临床试验 • 下一篇

脑白质高信号患者血清CX3CL1水平与认知功能障碍的关系

李琼¹, 赵建华^1*, 刘昊¹, 王凡¹, 李青¹, 陈希妍¹, 蔡瑞艳¹, 吴清武², 张健², 吉四辈¹, 路承彪³, 李少敏⁴

1.新乡医学院第一附属医院神经内科河南省神经修复重点实验室河南省老年性痴呆神经修复国际联合实验室,河南新乡 453000;
2.新乡医学院第一附属医院影像科,河南新乡 453000;
3.新乡医学院生理学与神经生物学教研室河南省无创性神经调制国际联合实验室,河南新乡 453000;
4.美国哈佛大学医学院布莱根妇女医院神经疾病研究中心,美国波士顿 02115

收稿日期:2022-10-24 出版日期:2023-02-21 发布日期:2023-01-13
基金资助:
国家自然科学基金(81771517),河南省自然科学基金项目(182300410389),河南省医学科技攻关计划联合共建项目(LHGJ20190437)。

The relationship between serum CX3CL1 level and cognitive dysfunction in patients with white matter hyperintensity

Li Qiong¹, Zhao Jianhua^1*, Liu Hao¹, Wang Fan¹, Li Qing¹, Chen Xiyan¹, Cai Ruiyan¹, Wu Qingwu², Zhang Jian², Ji Sibei¹, Lu Chengbiao³, Li Shaomin⁴

1. Henan Joint International Research Laboratory of Neurorestoratology for Senile Dementia, Henan Key Laboratory of Neurorestoratology Department of Neurology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan Province, China;
2. Imaging Department, First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan Province, China;
3. Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Neurobiology, Xinxiang Medical University, Xinxiang 453003, Henan Province, China;
4. Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston 02115, USA

Received:2022-10-24 Online:2023-02-21 Published:2023-01-13
Contact: *E-mail: 051092@xxmu.edu.cn
Supported by:
National Natural Science Foundation of China(81771517),Natural Science Foundation of Henan Province (182300410389), Joint Construction Project of Henan Medical Science and Technology Research Plan (LHGJ20190437).

摘要/Abstract

摘要： 目的探究脑白质高信号(white matter hyperintensity, WMH)患者血清趋化因子C-X3-C配体1(chemokine C-X3-C-motif ligand 1, CX3CL1),也被称作分形趋化因子(fractalkine, Fkn)的水平与认知功能障碍的相关性。方法纳入2020年3月至2022年8月于新乡医学院第一附属医院神经内科影像学表现有WMH的脑小血管病(cerebral small vessel disease,CSVD)住院患者,收集患者一般临床资料、头颅核磁常规序列、生化指标,测定CX3CL1水平及评估简易认知量表(Mini-mental State Examination,MMSE)、蒙特利尔认知评估量表(Montreal Cognitive Assessment,MoCA),分析血清CX3CL1水平与WMH及认知功能的相关性。结果共纳入152例受试者,根据MMSE结果分为认知功能正常组(77例)及认知功能障碍组(75例),平均年龄分别为(59.60±8.84) 岁和(62.91±7.99)岁。相关性分析结果显示CX3CL1水平与视空间与执行功能、注意力、定向力分别呈负相关性(r=－0.227,P=0.008、r=－0.186,P=0.030、r=－0.172,P=0.046)。回归分析结果显示CX3CL1水平、白质高信号严重程度及深部白质病变是认知功能障碍的危险因素。受试者工作特征 (receiver operating characteristic,ROC)曲线分析提示CX3CL1水平对认知障碍可能具有潜在的预测价值。结论血清CX3CL1水平、WMH与认知功能具有相关性,且血清CX3CL1水平升高是认知功能障碍发生的危险因素。

关键词: 趋化因子C-X3-C配体1, 脑白质高信号, 认知功能, 脑小血管病

Abstract: Objective To explore the correlation between serum chemokine C-X3-C-motif ligand 1 (CX3CL1), also know as fractalkine (Fkn). levels and cognitive dysfunction in patients with white matter hyperintensity (WMH). Methods A total of 152 patients with cerebral small vessel disease (CSVD) enrolled in the First Affiliated Hospital of Xinxiang Medical University from March 2020 to August 2022 were collected. The general clinical data of patients, the routine sequence of cranial magnetic resonance imaging (MRI), biochemical indicators, serum CX3CL1 level, and Mini-mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) cognitive scores were collected, and the correlation between serum CX3CL1 levels and white matter hyperintensity and cognitive function was analyzed. Results A total of 152 participants were enrolled and divided into the group with normal cognitive function and the group of cognitive dysfunction according to the MMSE results, with the mean age of (59.60±8.84) years and (62.91±7.99)years, respectively. The correlation analysis results showed that CX3CL1 level and apparent space were negatively correlated with executive function, attention, and orientation.Regression analysis showed that CX3CL1 levels and white matter high-signal were risk factors for cognitive dysfunction. Receiver operating characteristic (ROC) curve analysis suggested that CX3CL1 levels may have potential predictive value for cognitive impairment. Conclusion Serum CX3CL1 levels and white matter hyperintensity are associated with cognitive function, and elevated serum CX3CL1 levels are risk factors for the development of cognitive dysfunction.

Key words: chemokine C-X3-C-motif ligand 1 (CX3CL1), white matter hyperintensity (WMH), cognitive function, cerebral small vessel disease (CSVD)

中图分类号:

R742

李琼, 赵建华, 刘昊, 王凡, 李青, 陈希妍, 蔡瑞艳, 吴清武, 张健, 吉四辈, 路承彪, 李少敏. 脑白质高信号患者血清CX3CL1水平与认知功能障碍的关系[J]. 首都医科大学学报, 2023, 44(1): 6-12.

Li Qiong, Zhao Jianhua, Liu Hao, Wang Fan, Li Qing, Chen Xiyan, Cai Ruiyan, Wu Qingwu, Zhang Jian, Ji Sibei, Lu Chengbiao, Li Shaomin. The relationship between serum CX3CL1 level and cognitive dysfunction in patients with white matter hyperintensity[J]. Journal of Capital Medical University, 2023, 44(1): 6-12.

参考文献

[1] De Havenon A, Sheth K N, Yeatts S D, et al. White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment[J]. Stroke Vasc Neurol, 2022, 7(4): 364-366.
[2] Pawelec P, Ziemka-Nalecz M, Sypecka J, et al. The impact of the CX3CL1/CX3CR1 axis in neurological disorders[J]. Cells, 2020, 9(10): 2277.
[3] Harrison J K, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia[J]. Proc Natl Acad Sci U S A, 1998, 95(18): 10896-10901.
[4] Lauro C, Chece G, Monaco L, et al. Fractalkine modulates microglia metabolism in brain ischemia[J]. Front Cell Neurosci, 2019, 13: 414.
[5] Liu Y, Zhang T X, Meng D W, et al. Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism[J]. Behav Brain Res, 2020, 381: 112371.
[6] Liu Y, Wu X M, Luo Q Q, et al. CX3CL1/CX3CR1-mediated microglia activation plays a detrimental role in ischemic mice brain via p38MAPK/PKC pathway[J]. J Cereb Blood Flow Metab, 2015, 35(10): 1623-1631.
[7] Sheridan G K, Murphy K J. Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage[J]. Open Biol, 2013, 3(12): 130181.
[8] Bolós M, Llorens-Martín M, Perea J R, et al. Absence of CX3CR1 impairs the internalization of Tau by microglia[J]. Mol Neurodegener, 2017, 12(1): 59.
[9] Sunnemark D, Eltayeb S, Nilsson M, et al. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin[J]. J Neuroinflammation, 2005, 2: 17.
[10] Rogers J T, Morganti J M, Bachstetter A D, et al. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity[J]. J Neurosci, 2011, 31(45): 16241-16250.
[11] Suresh P, Phasuk S, Liu I Y. Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X7R signaling[J]. Tzu Chi Med J, 2021, 33(1): 1-6.
[12] Li A, Zhao J Y, Fan C Z, et al. Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease[J]. Neurobiol Aging, 2020, 86: 81-91.
[13] S′lusarczyk J, Trojan E, Wydra K, et al. Beneficial impact of intracerebroventricular fractalkine administration on behavioral and biochemical changes induced by prenatal stress in adult rats: possible role of NLRP3 inflammasome pathway[J]. Biochem Pharmacol, 2016, 113: 45-56.
[14] Zheng L, Wang Y, Shao B, et al. Multiple mild stimulations reduce membrane distribution of CX3CR1 promoted by annexin a1 in microglia to attenuate excessive dendritic spine pruning and cognitive deficits caused by a transient ischemic attack in mice[J]. Neurosci Bull, 2022, 38(7): 753-768.
[15] Lyons A, Lynch A M, Downer E J, et al. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro[J]. J Neurochem, 2009, 110(5): 1547-1556.
[16] Scianni M, Antonilli L, Chece G, et al. Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity[J]. J Neuroinflammation, 2013, 10: 108.
[17] 于鸿益, 贾仲仪, 张忠玲. 小胶质细胞参与脑白质高信号病理生理学的机制[J]. 国际脑血管病杂志, 2021, 29(6): 467-470.
[18] Meng L F, Zhao J H, Liu J L, et al. Cerebral small vessel disease and cognitive impairment[J]. J Neurorestoratology, 2019, 7(4): 184-195.
[19] Zhang Q X, He L, Chen M, et al. PSD-93 mediates the crosstalk between neuron and microglia and facilitates acute ischemic stroke injury by binding to CX3CL1[J]. J Neurochem, 2021, 157(6): 2145-2157.
[20] Bemiller S M, Maphis N M, Formica S V, et al. Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy[J]. J Neuroinflammation, 2018, 15(1): 278.
[21] Winter A N, Subbarayan M S, Grimmig B, et al. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice[J]. J Neuroinflammation, 2020, 17(1): 157.
[22] Takei Y, Amagase Y, Iida K, et al. Alteration in peritoneal cells with the chemokine CX3CL1 reverses age-associated impairment of recognition memory[J]. Geroscience, 2022, 44(4): 2305-2318.
[23] Bollinger J L, Wohleb E S. The formative role of microglia in stress-induced synaptic deficits and associated behavioral consequences[J]. Neurosci Lett, 2019, 711: 134369.
[24] Bollinger J L, Collins K E, Patel R, et al. Behavioral stress alters corticolimbic microglia in a sex-and brain region-specific manner[J]. PLoS One, 2017, 12(12): e0187631.
[25] Spiteri A G, Wishart C L, Pamphlett R, et al. Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function[J]. Acta Neuropathol, 2022, 143(2): 179-224.
[26] Nash K R, Lee D C, Hunt J B, Jr, et al. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy[J]. Neurobiol Aging, 2013, 34(6): 1540-1548.

脑白质高信号患者血清CX3CL1水平与认知功能障碍的关系

The relationship between serum CX3CL1 level and cognitive dysfunction in patients with white matter hyperintensity

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	安宇, 边南南, 丁小雨, 常晓娜, 刘佳, 王广. 1型糖尿病伴认知功能损伤小鼠脑组织肠道菌群代谢物的改变[J]. 首都医科大学学报, 2022, 43(4): 622-629.
[2]	许新, 阮祥燕, 鞠蕊, 杨瑜, 程姣姣, 王志坤, Alfred O. Mueck. 中国女性轻度认知障碍的影响因素及其与绝经症状的关系[J]. 首都医科大学学报, 2022, 43(3): 369-374.
[3]	任艳萍, 张俊岩, 吴涵, 罗炯, 杨春林, 马辛, 姜玮. 磁惊厥治疗与无抽搐电痉挛治疗抑郁发作的早期疗效及对认知功能的影响[J]. 首都医科大学学报, 2022, 43(2): 239-243.
[4]	王含誉, 张雅文, 郭肖瑶, 程宏发, 张秋霞. 基于中医传承辅助平台分析中医药治疗脑小血管病的用药规律[J]. 首都医科大学学报, 2022, 43(2): 254-259.
[5]	杨柳青, 田红梅, 石汉平. 三种饮食模式与慢性疾病研究进展[J]. 首都医科大学学报, 2022, 43(2): 311-320.
[6]	李志, 张郡, 戴悦萱, 秦明阳, 梁芙茹. 血糖波动对2型糖尿病大鼠认知功能的影响[J]. 首都医科大学学报, 2021, 42(3): 347-353.
[7]	郝淑文, 陈瑛, 丁晖, 赵春松, 梁阔, 薛金花, 蔡彦宁. 阿尔茨海默病、轻度认知功能障碍及主观认知下降患者血液DNA中多个基因的甲基化分析[J]. 首都医科大学学报, 2021, 42(3): 447-452.
[8]	张颖, 王若梅, 李刚. 稳定期精神分裂症患者认知功能、情绪管理水平及其影响因素分析[J]. 首都医科大学学报, 2021, 42(1): 143-147.
[9]	吴凤芝, 宁艳哲, 贾竑晓. 脾虚证患者认知功能的临床特征[J]. 首都医科大学学报, 2020, 41(1): 55-58.
[10]	宋楠, 贾竑晓. 人格解体患者认知功能及与临床症状和社会功能的相关性[J]. 首都医科大学学报, 2020, 41(1): 59-63.
[11]	李森, 黄安琪, 郭健飞, 白洁, 张光珍, 王婷, 赵咏梅. 沙格列汀对2型糖尿病患者缺血性脑卒中后认知功能的影响[J]. 首都医科大学学报, 2019, 40(5): 715-720.
[12]	陈玉静, 陈文强, 张建新, 刘妍, 吴犀翎, 王建东, 黄小波. 黄芩甙对慢性脑低灌注大鼠认知功能及其对海马内LC-3Ⅱ和Beclin-1表达的影响[J]. 首都医科大学学报, 2019, 40(3): 330-334.
[13]	刘毅, 任艳萍, 姜玮, 马辛. 基于神经心理与生理学评估的精神分裂症无抽搐电休克治疗后认知功能的研究[J]. 首都医科大学学报, 2018, 39(5): 651-656.
[14]	穆珊珊, 吴延, 吴安石, 刘扬. 非心脏手术老年患者术后谵妄及术后认知功能障碍相关危险因素研究[J]. 首都医科大学学报, 2018, 39(3): 366-372.
[15]	朱虹, 职利花, 贾竑晓. 齐拉西酮治疗对精神分裂症患者认知功能和生活质量的治疗效果研究[J]. 首都医科大学学报, 2018, 39(2): 199-203.